Nurmohamed M, Choy E, Charles-Schoeman C, et al. Impact of Tofacitinib Treatment Compared with Placebo or Methotrexate on Cardiovascular Risk Scores in Six Phase 3 Randomized Controlled Trials. ACR 2017, abstract 2966.
ACR Winter Rheumatology Symposium: nieuwe ontwikkelingen in behandelingen
feb 2022 | Artrose, RA, Spondyloartritis, Vasculaire geneeskunde